Buy or sell SQZ Biotech stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

SQZ Biotech Stock

SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies.

Founded

2013

Notable Investors

NanoDimension

Headquarters

Watertown MA, US

Total Funding

$101M

About SQZ Biotech Stock

SQZ Biotechnologies is a Massachusetts-based, privately held company developing cellular therapies for multiple indications using the proprietary CellSqueeze® technology. Through internal research programs and external partnerships, SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies by engineering the immune system both through immune activation and immune suppression for a wide range of clinical challenges.

Investors

Funding History

April 2014$15K
October 2014$100K
June 2015$5.0M
September 2016$16.0M
December 2016$8.3M
August 2018$72.0M

Management

Director of Strategic Scientific Partnerships

Jonathan Gilbert

CEO

Armon Sharei

Chief Scientific Officer

Howard Bernstein

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from SQZ Biotech or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 140K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo